Alnylam Pharmaceuticals, Inc. (ALNY)

362.25 +6.72 (+1.89%) USD  |  NASDAQ  |  Jan 21, 15:08
More

Alnylam Pharmaceuticals Proceeds from Stock Option Exercised (Annual)

Proceeds from Stock Option Exercised (Annual) Chart

View Proceeds from Stock Option Exercised (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Annual) Benchmarks

View Proceeds from Stock Option Exercised (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade